Screening of some South African seaweeds for prostaglandin-synthesis inhibitors  by Stirk, W.A. et al.
108 S. Arr. J. Bot. 1996,62(2): 108-110 
Screening of some South African seaweeds for prostaglandin-synthesis inhibitors 
W.A. Stirk*, A,K, Jager and J, van Staden 
NU Research Unit for Plant Growth and Development. Botany Department, University of Natal Pietermaritzburg, Private Bag X01 , 
Sconsvi lle, 3209 Republic of South Africa 
Rel.."eil1ed 13 September 1995: revised 5 December J995 
Ethanol and water extracts of thirty-four seaweeds collected from the KwaZulu-Natal and Cape coasts were screened 
for prostaglandin-synthesis inhibitors using the cyclooxygenase bioassay. Inhibitory activity was detected in certain 
species collected from both the KwaZulu-Natal and Cape coasts. There were no taxonomic trends, with some species 
from the Chlorophyta, Phaeophyta and Rhodophyta showing inhibitory activity. Highest levels of inhibitory activity were 
detected in the ethanolic extracts. 
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Introduction 
The earliest records of usc of algae for medicinal purposes shows 
that they were used in China around 2700 BC (Hoppe 1979), The 
potential for use of marine algae is grear, including treatment 
against malnutrition, because seaweeds are rich in proteins, vita~ 
mins and trace clements, and treatment of goitre, owing to the 
high levels of iodine present. Sargassum bacciferum (Turn.) 
C.Ag. is used by South American Indians for this latter purpose. 
A few algal species contai n vermifugal substances and Digenea 
simplex (Wulfen) C.Ag. is used as a vermifuge, where a.·L-kainic 
ac id and a~L-allokainic acid have been isolated as the active 
compounds. Extracts of Laminaria species have been used as 
anti ~coagu lants, and many algae have antibiotic activity, although 
nonc of these substances is presently used phannaceutically. 
Marine algae also show selective removal of poisonous heavy 
metals owing to the selective binding capacity of alginic acid and 
other acid polysaccharides (Michanek 1979; Nisizawa 1979). At 
present, the most widely used seaweed compounds in medicine 
are agars, carrageenans and alginates. which arc used as binding 
agents and in dentistry (Chapman 1979). 
There is increasing interest in the utilization of marine algae 
for pharmaceutical purposes, as they may offer sources of natural 
products which differ from terrestrial plants and animals, thus 
providing potentially new biomedical leads. Most work to date 
has looked at natural compounds with pharmaceutical potential 
from marine animals. 
Prostaglandins cause pain and inflammation in animal cells. 
They are derived from arachidonic acid, which is released from 
cell wa lls. One of the key enzymes in prostaglandin biosynthesis 
is cyclooxygenase. If this enzyme can be inhibited and thus tess 
prostaglandin produced, one has a potential remedy for inflam-
mation. Aspirin and other non-steroid anti ~inf1ammatory drugs 
block cyclooxygenase. 
The aim of this work was to screen a number of crude seaweed 
extracts for compounds which inhibit prostaglandin synthesis, in 
order to identify sources of potentially important metabolites for 
subsequent development. 
Materials and Methods 
Material was collected from Rocky Bay, KwaZulu·Natal in Septem~ 
ber 1994 and from Kommetjie, Western Cape in December 1994. 
Identification was done with the aid of herbarium specimens housed 
in the University of Natal Herbarium (NU). Epiphytes were removed 
from the material, which was then freeze~dried and stored at - 20°C. 
The dried material was ground into a fine powder and 500 mg was 
used for each extraction, which was carried out for 30 min in an 
ultrasound bath in either 5 mI waler or ethanol. The extraction mix~ 
tures were then centrifuged for 10 min at 2 000 r.p.m. and the supcr~ 
natants decanted and taken to dryness ill vacuo . The residues were 
resuspended in either water or ethanol respectively. giving 2.5 mg 
residue mI-! water and 20 mg residue mI·t ethanol. 
The extracts were screened for prostaglandin~synthesis inhibitors 
using the cyclooxygenase bioassay, as described by Jager et al. 
(1996). Ten microlitres (OJ I-lg protein) of sheep seminal vesicle 
microsomes and 50 I-ll of cofactor solution (L~adrenalin and reduced 
glutathione, 0.3 mg ml· t each in 0.1 M Tris buffer, pH 8.2) were pre-
incubated on ice for 15 min. Twenty microliLres solvent, test or 
standard solution (20 JlI of aqueous solutions; 2.5 1-'1 of ethanolic 
solutions + 17.5 J.1I water) and 20I .. iI [ 14CJ-arachidonic acid (16 Ci 
mole-!. 30~) were added and the assay mixture was incubated at 
37°C for 10 min. The reaction was terminated by adding 10 J.1I 2N 
HC!. A blank sample was kept on ice. After incubation, 5 J.1I of a O.2~ 
rug mI·! carrier solution of unlabelled prostaglandins (PGE2;PGF2 
I: I v/v) was added. The prostaglandins were separated from un~ 
metabolized arachidonic acid by column chromatography on sil ica 
ge l. Arachidonic acid was eluted with 5 ml hexane :dioxane :acetic 
acid (350; 150 :1 v/v). The prostaglandins were eluted with 3 ml 
ethyl acetate: methanol (85: 15 v/v) directly into scintillation vials 
and radioactivity was counted using a Beckman LS 380 I scintilla~ 
tion counter. 
All experiments were performed in duplicate. If the range was 
greater than 10% for anyone species, the experiment was repeated 
for that particular species. 
Results and Discussion 
The results of the screening of common KwaZulu-Natal and 
Western Cape seaweeds for prostaglandin-synthesis inhibitors 
are shown in Tables I and 2 respectively. The geographical distri~ 
bution of the species did not overlap between the two collection 
sites. 
A certain level of unspecific inhibition occurs in enzyme 
assays, but in order (Q select species for further study. an exclu-
sion criterion of 70% inhibition was set in the cyclooxygenase 
assay. Any species with inhibition higher than this was consid-
ered active against prostaglandin synthesis. Indomethacin, a 
commercial anti-inflammatory drug, showed 73% ± 9% inhibi-
tion at 2 x to-5 M. The exclusion criterion used for selection in 
our studies may have been too high or too low, but it served as a 
working criterion for selection of potentially active species. 
The highest inhibitory activity for all species tested was found 
when samples were ex tracted with ethanol, and most of the eth~ 
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Table 1 Prostaglandin-synthesis inhibition by common 
KwaZulu-Natal macroalgae 
Inhibition (%) 
Ethanol Water 
Species extract extract 
Indomethacin std. (2 x 10·' M) 73 ± 9 
Chlorophyta 
Call(erpa racemo.w (Forsskal) J.Ag. 92 3 
Caulerpa fil(fornm (Suhr) Hering 70 
ClJdiulIl capitatum Silva 52 5 
Bry'ofJJis sp. 74 13 
Halimeda nmcala Hering in Krauss 66 3 
Chamaedoris de/phil1ii (Hariot) Feldm. et Baerg. 92 32 
Phaeophyla 
ZOflaria .wbarficulara (Lamour.) Papenf. 98 78 
SargaHul/l hetemphyllum (Turn.) C.Ag. 97 52 
Rhodophyta 
Gelidium amaflsii (Lamour.) Lamour. 47 44 
Amphiroa ephedraefl (Lamarck) Decaisne 94 25 
ArriJr(J{.:ardia sp. 81 17 
Cheil(Jspnrum sp. 77 52 
Jania sp. 46 20 
Plt/mmium .whrii Klilz. 53 15 
H}'pnea spicifera (Suhr) Harv. 46 27 
Spyridia wpprcJsina (Harv.) Klitz. 76 30 
Ca/lirhamnilJn sIUfJ().~llm Suhr 89 70 
Ltmrem:ia natalensiof Kyl. 65 37 
anolic extracts showed considerable inhibition of cyclooxygen-
ase. Generally. the water extracts did not meet the 70% criterion 
considered for activity, with only two exceptions, i.e. Zonaria 
subarticufata and Caliithamniol1 stuposum. 
There appeared to be no general taxonomic trends in the 
amount of inhibitory activity observed, although the Phaeophyta 
as a whole displayed the highest activity in both the ethanalic 
and water extracts. However. it is with uncertainty that such a 
generalization can be made. as only a few brown algal species 
were tested, owing to their low diversity. The Rhodophyta dis-
played some of the lowest levels of activity. although there were 
some species with considerable potentia1. There were also cer-
tain Chlorophyta which had potential for Further investigation. 
There appeared to be no general trends in geographical loca-
tion of the algae concerning prostaglandin-synthesis inhibition. 
The ethanolic extracts of Amphiroa ephedraea and Callitham-
"ion stuposum from the warmer KwaZulu-Natal coast and Car-
radoria virgata, Suhria vittata and Carpoblepharis flaccida from 
the colder, more nutrient-rich Western Cape coastal waters all 
showed over 90% cyclooxygenase inhibition. 
Inhibitors of cyclooxygenase come from many classes of sec-
ondary metabolites. including alkamides (MUller-Jakic el al. 
1994), phenol ic compounds (Pongprayoon el 01. 1991), poly-
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Table 2 Prostaglandin-synthesis inhibition by common 
Western Cape macroalgae 
Species 
Indomethacin std. (2 x 10.5 M) 
Chlorophyta 
Ulva c:apensis Aresch. 
CladlJphorajIagell!formis (Suhr) Klitz. 
Cladophora L·apen.ri.\· (C.Ag.) De Toni 
Codium/ragile (Suhr) Harv. subsp. mpense 
Sil va 
Phaeophyta 
Laminaria pallida Grev. ex I.Ag. 
Macrocystis angusrifolia Bory 
Ed/onia maximo (Osbeck) Papenr. 
Rhodophyta 
Porphyra capensis Klitz. 
Cluwangiutn erinaceum (Turn.) Papenf. 
Suhria virwta (L.) J.Ag. 
Aeodes orbitosa (Suhr) Schmitz 
Pochymenia carnosa (I.Ag.) J.Ag. 
Giganino poiycarpa (Klitz. ) Setch. ex Gardner 
SarC:(Jthafia Sfiriata (Turn.) J.Ag. 
CarpohlepiJari.sflaccida (C.Ag.) Klitz. 
Carradoria virgata (C.Ag.) Kyl. 
Inhibition (%) 
Ethanol 
ex tracl 
73 ± 9 
Water 
extract 
83 17 
95 7 
96 41 
87 10 
78 7 
82 43 
93 
84 20 
74 57 
91 9 
80 7 
59 0 
62 2 
88 33 
90 0 
93 15 
acetylenes (Redl ef al. 1994) and sesquiterpenes (Nasiri ef al. 
1993). The nature of the active compounds in the species used in 
this study is still unknown. 
Seaweeds from other parts of the world have previously been 
tested for anli-inflammatory aClivity. Paya el ai, (1990) and Bus-
tos et al. (1992) screened a number of Mediterranean seaweeds, 
using the carrageenin-induced mouse paw edema bioassay to test 
topical anti-inflammatory activity. and found that some species 
showed activi ty. Wiemer et at. ( 1991) isolated two new bromo-
phenols, vida lois A and B from Ihe red alga Vidalia oblumlaba 
(Mert.) I .Ag. These are anti -inflammarory agents which function 
through Ihe inhibition of phospholipase A,. These vidalols 
appear to be involved in defense against diverse marine herbiv-
ores (Wiemer et al. 1991). Two novel metabolites derived from 
arachidonic acid have been isolated from the red alga COflstan-
tinea simples Setch .• and show modest anti-inflammarory ac tivity 
via inhibition of phospholipase A, (Gerwick el al. 1991). 
According to fossil records, eucaryotic algae have been in 
existence for approximately 700-800 million years (Lee 1980) 
and therefore they have had sufficient time to develop biosyn-
thelic pathways for diverse and unique compounds. Seaweeds 
hold great potential for the discovery of new and unusual com-
pounds that could be used for pharmaceutical purposes. Future 
research will focus on those algal species showing greatest 
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potential in our screening. and will attempt to isolate some of the 
active compounds by bioassay-guided fractionation . 
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